HMS Valuation Partners is a well-established and reputable firm specializing in providing comprehensive valuation and consulting services exclusively for the healthcare industry. With over 20 years of consistent business performance, the company has served a wide range of clients including multi-national hospital systems, regional and local health systems, large and small physician groups, and various healthcare law firms. Their extensive expertise allows them to guide clients through a diverse array of economic transactions, such as mergers & acquisitions, physician compensation arrangements, time-share values/real estate, professional services agreements, and other healthcare transactions.
One of the key differentiators of HMS Valuation Partners is their deep understanding of the healthcare industry's unique relationships, requirements, and issues. This enables them to go beyond the numbers and deliver value that extends to compliance challenges and smart deal completions. The company has an impressive track record of more than 12,000 deals and opinions, showcasing their experience in handling complex circumstances and arrangements with efficiency and accuracy.
Their team comprises highly skilled healthcare valuation experts with strong academic backgrounds, recognized industry certifications, and extensive experience in areas such as public health, health administration, mergers and acquisitions, finance, accounting, operations, risk management, negotiations, and compliance. This expertise positions them as specialists in various aspects of healthcare valuation, ranging from Business Entity Valuation to Physician Compensation and Hospital-Based Service Line Coverage.
Although specific details about their recent investments and investors are not publicly available, HMS Valuation Partners continues to demonstrate its industry leadership and commitment to delivering high-quality services that inspire security, confidence, and trust in the numbers for its clients within the Health Care sector in the United States.
There is no investment information